Here, we reported the case of a ponatinib-resistant Ph + ALL patient harboring a novel insertion mutation p.I293_K294insSSLRD located in the BCR::ABL1 kinase domain. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.